PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies.

Salem, Ahmed Ebada; Fine, Gabriel C; Covington, Matthew F; Koppula, Bhasker R; Wiggins, Richard H; Hoffman, John M; Morton, Kathryn A

Salem, Ahmed Ebada; Fine, Gabriel C; Covington, Matthew F; Koppula, Bhasker R; Wiggins, Richard H; Hoffman, John M; Morton, Kathryn A.

Afiliação

Salem AE; Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USA.
Fine GC; Department of Radiodiagnosis and Intervention, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.
Covington MF; Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USA.
Koppula BR; Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USA.
Wiggins RH; Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USA.
Hoffman JM; Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USA.
Morton KA; Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USA.

Cancers (Basel) ; 14(12)2022 Jun 18.

Article em En | MEDLINE | ID: mdl-35740665

Palavras-chave

PET; [18F]-fluorodeoxyglucose; fluciclovine; gynecologic malignancy; penile cancer; prostate cancer; prostate specific membrane antigen (PSMA); renal cell carcinoma; testicular cancer; urothelial carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google